The Fasa Registry on Systolic Heart Failure (FaRSH): Feasibility Study and the First 5-year Reports

Background: The literature on patients with heart failure (HF) from the Middle East, besides a few existing registries, is scarce. We report, for the first time in our country, a hospital-based registry for systolic HF. Materials and Methods: This was a web-based registry on HF, conducted in Vali-Asr Hospital affiliated with Fasa University of Medical Sciences, Fasa, Iran. The goal of this registry was to define overall baseline clinical characteristics and natural history of hospitalized patients with systolic HF, to evaluate current management schema and implementation of practice guidelines, and to determine the correlation between genetic predisposition environmental effects, individuals’ characteristics of health, lifestyle, morbidity, and mortality in relation with the effects of medication. Results: To date, 2378 individuals with a mean of age 67.08±13.07 years have been registered. Among which, 1381 (58.07%) patients were diagnosed with denovo HF. Most of the patients (60.1%) were male, and 8.9% had admissions during the past 30 days. The most common causes of HF were ischemic heart disease (86.5%) and hypertension (5.3%). Most patients had NYHA class one (44.3%) and three (20.4%). Overall, near 30% had diabetes and more than 38% had hyperlipidemia. Most individuals have been not a history of cigarette smoking (68.7%) or water-pipe smoking (96.9%). Also, 22.2% were current opium users, and 3.2% were previous opium users. Conclusion: The findings of this registry could make a realistic view of HF as a chronic disease with a burden. Therefore, policymakers can design programs and guidelines to prevent disease and better survival and quality of life.


Introduction
Among the most common and disabling diseases of the 21 st century is heart failure (HF). Despite significant advances in the management of the disease, it still affects an estimated 26 million individuals worldwide [1]. Managing the disease involves a multidisciplinary strategy, as the disorder is associated with a substantial decline in quality of life and is associated with many medical and social challenges [1,2]. Most guidelines and treatment protocols designed for patients with HF are based on data obtained from North America and Europe and by evaluating large registries, including the Acute Decompensated HF National Registry (ADHERE) [3] and the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with HF (OPTIMIZE-HF) study [4]. Epidemiological data, which may affect protocol and treatment guidelines from other regions of the world, especially Asia, remains scarce [5]. Moreover, HF rates are increasing and among the most important factors contributing to the increased rates of HF is the transformation seen in the age pyramid, especially in Iran [6], as the population has transformed from a very young population to an older population [6]. Furthermore, due to advances in health care, survival after a cardiac event has increased over the past years, which itself increases HF rates [7,8]. Reports of patients with HF from the Middle East, besides a few existing registries, are scarce. This poses a major barrier for global collaborations and inhibits correct comparison of HF status and discussion on common issues in the management of HF. Here we report, for the first time in our country, a hospital-based registry for the evaluation of systolic HF and its correlates within our region.

Study Settings
This was a detailed description of our registry on systolic HF termed the Fasa Registry on Systolic HF (FaRSH, https://ncdrc.fums.ac.ir/ activities/disease-registries/farsh). This is a hospital web-based registry on HF, conducted in Vali-Asr Hospital as the first affiliated hospital of Fasa University of Medical Sciences (FUMS), Fasa, a city in Fras province, southeast of Iran, under the supervision of and funded by the Ministry of Health. The study was carried out by the Cardiology Department and the Noncommunicable Diseases Research Center (NCDRC) of FUMS. Vali-Asr Hospital is a university teaching hospital, fully equipped with chest pain units as well as coronary care unit (CCU), intensive care unit (ICU), catheterization lab, and cardiac surgery rooms for emergency interventions. It is a third-level referral center for 220 000 citizens residing in Fasa and 34 nearby towns and villages. One other medical center proximate to Fasa city also has general emergency departments. However, almost all patients with significant cardiovascular signs and symptoms are referred to Vali-Asr hospital for emergency and routine cardiac attention in about 600 000 subjects, including nearby cities and towns.

Registry Objectives
The goals of this registry were (1) to define the overall baseline clinical characteristics and natural history of hospitalized patients with systolic HF in our region, (2) to evaluate the current management schema of systolic HF in the region, and to explore whether practice guidelines are implemented, (3) to evaluate further outcomes of patients with HF, and (4) to establish an infrastructure for further research and also their treatment on systolic HF. Other objectives include (5) to assess the correlation between treatment strategies and in-hospital and long-term outcomes, (6) to evaluate and compare the cost-effectiveness of medical and device therapies in HF, (7) and to determine the correlation between genetic factors and morbidity and mortality in relation with the effects of medication. Due to regulation of the Iranian communication law data gathering and handling were done. and medical records. Admissions with a diagnosis of systolic HF would be included in the registry. Aside from evaluating patients' records, the nurses also conducted face-toface interviews with each patient and/or their family to obtain data, according to the predesigned data sheets and questionnaires. In cases where missing data existed, the primary attending physician who was responsible for that patient's treatment was available, and related data were obtained by referring to the treating physician. Registration was done electronically using an android tablet and through an online registration system. Throughout the university network framework, data were then processed on a cloud server that had stable firewalls. The flowchart of this registry design has been represented in Figure-1.

Variables and Their Definitions
The variables included in the study and their definition and classifications are reported in Table-1 and Table-2.

Follow-up
After patients entered the registry, they were included in the electronic registration system. The online software, which included patients' information, would notify the registry nurses regarding each patient's follow-up appointments. After which, each patient or their relatives was contacted, and information regarding any cardiac or non-cardiac events was questioned. Specific questions were asked regarding cardiac interventions, other hospital admissions, events of bleeding, and stroke. In cases of any events, the patient or their relatives were interviewed regarding the event. In cases of any hospitalization or death, patients' medical records were reviewed and analyzed.

Data Quality and Control
The electronic registration system notified the nurse who registers patients' data in cases of missing or unusual data entry. A working team of research assistants monitors and verify data entry weekly. The central database was further analyzed monthly by a steering committee, and completeness of data was assured. Data regarding the etiology of HF, including significant valvular heart disease and dilated cardiomyopathy (DCM), the existence of atrial fibrillation, reasons for cessation or decrease in the dose of drugs (such as angiotensin-converting enzyme [ACE] inhibitors, angiotensin receptor blockers [ARBs], beta-blockers, and mineralocorticoid receptor antagonists [MRA]) were entered in the registry database by validation of the attending cardiologist through the electronic system. Other data, including New York Heart Association (NYHA) class was measured and registered by the trained registry nurses who interviewed patients on their first day of admission.

Statistical Analysis
Data analysis was done using the SPSS® software for windows ® , version 17 (SPSS Inc., Chicago, IL, USA). Quantitative data were presented as mean±standard deviations (SD), and qualitative data were presented as frequency (percentage). Patients were classified into two groups of denovo HF and acute on chronic HF (ACHF). Means of normally distributed quantitative data were compared between the two groups using the independent T-test. Qualitative data were compared using the Chi-square test. A P-value of less than 0.05 was considered statistically significant. A systolic blood pressure of ≥140 or a diastolic blood pressure of ≥90

Hypertension treatment
Not receiving any treatment, those on non-pharmacological treatment (like traditional medicine), those on oral medications Hyperlipidemia TG>200mg/dl or total cholesterol of >240mg/dl

Hyperlipidemia treatment
Not on any treatment, on diet control, on oral medication, or unknown treatment.

Diabetes treatment
Not receiving treatment, those on diet control, on oral medication, on insulin, or finally on treatment that was unknown Cigarette, water pipe, and opium user Current smokers, ex-smokers, and never smokers

Type of opium
(An individual who smoked 100 cigarettes in his/her life was considered a smoker. For water pipe and opium, only history of regular use was considered when labeling individuals as users)

Dose of opium
Opium, opium extract (or Shire), and other types

Previous episodes of MI
Less than once a week, 1-4 times a week, 5-9 times a week, 10-14 times a week, and more than 14 times a week Previous episodes of MI

Discussion
According to the global burden diseases study, cardiovascular disease (CVD) has been the major cause of death between 2010 and 2015 in Iran, accounting for more than 20% of all diseases and 46% of any and all mortality [12]. Previous reported data of the prevalence of CVD and its prediction in the Fasa region [13] signify the importance of heart (-related) diseases. Here we gave a detailed description of our registry on systolic HF in Iran termed the FaRSH. Aside from clarifying practice routines and patients' appliance with treatment modalities, reasons for re-admissions, and medical treatment alterations, the FaRSH registry provides insight, for the first time, GMJ.2021;10:e2111 www.gmj.ir 9 ACHF: Acute on chronic heart failure; AHF: Acute heart failure; ACE: Angiotensin-converting enzyme; ARB: Angiotensin II receptor blockers; MRA: Mineralocorticoid receptor antagonists; ASA: Acetylsalicylic acid on systolic HF status in our country and to our knowledge, this is the first of its kind in Iran. We found that most individuals in our population were males, never smokers, never water pipe and opium users, and had a normal BMI. The majority of patients were referred due to symptoms of ACHF. In other words, most patients did not know that they had HF. Also, most individuals had no previous hospitalization, but in those with a previous history of hospitalization, most of them had an admission more than 30 days before, most patients had HF for less than six months. Near 52% had hypertension, near 30% had diabetes, and more than 38% had hyperlipidemia. Also, near 20% of individuals underwent CABG, and almost 26% underwent PTCA. In Asia, more than ten registries exist on HF, which are mostly located in Japan [1,14,15], China [15][16][17], Taiwan [15,18,19], and South Korea [15,20]. Despite these efforts, data on HF from the Middle East is still GMJ.2021;10:e2111 www.gmj.ir largely missing, and only a few studies [21][22][23] have been conducted in this region on HF epidemiology in the context of a prospective HF registry.
In the Euro HF registry, reported by Nieminen et al. [24], among 3580 individuals from 133 hospitals, they found a mean age of 69.9 years among their HF patients. Also, the Swedish HF registry reported that the mean of the included patients was 75 years (range 17-103) [25]. Moreover, in the ADHERE registry [26] that evaluated 105388 patients from 274 hospitals from across the United States, they found a mean age of 72.4 years among their patients with HF. This was significantly higher than that reported by the GULF registry (59 years old) [27]. We found the mean age of participants in our study was 67.08 years, this shows that Iranian patients are affected by HF in an age between neighboring countries (namely those in the GULF study) and that of Western countries. Among the few studies that have been conducted in the Middle East, Sulaiman et al. [27] studied individuals with HF in 47 hospitals from the Middle East. In their study (the GULF registry), they found that 61% of their participants (vs. 52% in our study) had hypertension, 50% (vs. 30% in our study) had diabetes, 36% (vs. 38% in our study) had hyperlipidemia, and 22% (vs. 20.6% in our study) were smokers. Most of their patients were classified as NYHA class three and four (43% and 32%, respectively) [27], which in comparison to our study, most of our patients were classified into NYHA class one (44.3%), followed by class three (20.4%) was much different. Ischemia was considered the leading cause (53%) of HF, followed by hypertension (16%) [27]. In our study, the first leading cause of HF was ischemic heart disease with 86.5%, and the second one with 5.3% was hypertension. Another prospective registry from the Middle East is the heart function assessment registry trial in Saudi Arabia (HEARTS) [28], conducted in Saudi Arabia. Similar to the GULF registry [27], they found a lower mean age among participants with acute and chronic HF (60.6 and 56.9 years, respectively). Their population had higher BMI (29.3 and 29.2kg/m 2 among individuals with acute and chronic HF, respectively), hypertension (70% and 75% in acute and chronic HF, respectively), hyperlipidemia (36.4% and 57.1% in acute and chronic HF, respectively), and diabetes (60.7% and 53% in acute and chronic HF, respectively). They found that 59% of their patients presented with NYHA classes three and four; furthermore, DCM (45%), coronary artery disease (40%), and hypertension (10.7%) were the most common causes of HF (aside from pregnancy-related cardiomyopathy) [28]. Overall, our HF patients seemed to have less severe conditions than the mentioned studies from the Middle East. This could be attributed to multiple factors. The first relates to the differences in baseline characteristics seen between the populations. Body fat mass, metabolic syndrome and its component, especially waist circumference and blood pressure, have been associated with electrocardiogram parameters and abnormalities [29,30] which may be factors associated to these differences in comparison to other populations. Second relates to the study sample selection between studies, as our study included individuals from a single center in Fasa city, and perhaps patients with more severe conditions are referred to centers in the main city of the province (Shiraz city). This study primarily was a report on protocol and preliminary findings and correct comparison with other studies from different regions may not be correct considering the main goal of the study and will be addressed in future upcoming studies. In addition, many of these studies included individuals who presented with either systolic or diastolic HF, while our registry only includes individuals with systolic HF. Thus, a precise comparison cannot be performed with most previous registries as some clinical characteristics of these conditions may differ. One of the most interesting findings was that almost 9% of our patients had a previous hospital admission during the last 30 days. This is alarming as it shows a flaw in the treatment process. Either patients were discharged too early and/or treatments were not followed by the individual as prescribed This registry records specifics on opium consumption, including dose, frequency, and type of opium. This provides an opportunity to study the associations between opium inhalation and HF, which is a subject of much controversy in literature [31][32][33]. Among other novelties in this registry, we further evaluated reasons for not prescribing HF medication or not prescribing the therapeutic dose of medications for each individual separately.
This allows a precise evaluation of obedience to guidelines in the management of HF. Drug consumption in our findings was another interesting point. ASA-antiplatelets drugs with 98.7% were at the first rank of medication use, followed by statins and anticoagulants, all with more than 90% usage. This broad use of medications in our region was surprisingly generally higher than other studies [34]. The reason for this wide use, the economic burden of this usage, and the compatibility of these drug administration with guidelines should be investigated further. The national health system absolutely would have benefited from the results of the further studies. Our health care system is divided into different health care sectors; they are each responsible for reporting to the medical university. This allows for a more detailed and reliable evaluation of the health status and offers a more effective means of collecting data in our research area.
Therefore, the study follows up can be fortified with the help of health care workers in these sectors. Our registry includes more than 180 variables that are recorded from each patient. Data entry, as mentioned before, was performed by two dedicated and trained nurses under the supervision of a senior cardiologist; furthermore, data were re-evaluated weekly by a team of research assistants who are specifically trained for handling the data. As Vali-asr Hospital was assigned for data registry on systolic HF, attending cardiologists at the center assist in the precise diagnosis of the condition. Patients' personal data and course of the disease, including treatment modalities and outcomes are not allowed for disclosure for the general population, which certifies that treatment routines applied by the cardiologists at the medical care center would not be altered by the time the study is being conducted. Furthermore, since we had an observational method of data gathering, no specific treatment protocol depicted by the registry administrators was applied, thus not leading to any changes in routine treatments. Data acquisition included both medical history assessment by reviewing medical records and direct face-to-face interviews performed by the personnel, which increases the credibility of the data and compensates for the retrospective nature of data gathering seen in other registries. Our study has some limitations. Although clinical evaluation followed guideline-specific protocols, each individual's final diagnosis and treatment modalities were determined according to the treating physicians' clinical judgment. Also, our study was a singlecenter registry and may not be completely representative of the whole country. Unlike many previous registries on HF, we collected post-hospitalization clinical data, including revascularization, re-hospitalization, appliance to medical therapy, etc., that allows a precise evaluation of long-term outcomes. Our study only includes the territory covered by Fasa city. Furthermore, many individuals refer to Shiraz city (as the largest city in the Fars province) for medical care; therefore, the registry cannot claim to cover all hospitalized 10. Bahramali E, Askari A, Zakeri H, Farjam M, Dehghan A, Zendehdel K. cases of HF within the region. This registry was the first of its kind in the country, and the study results will be used as a baseline study for further and larger upcoming registries.

Conclusion
We are conducting the first hospital-based registry for systolic HF in Iran, which could help policymakers obtain a more realistic view of one of the most financially demanding chronic diseases in the country. We can define the costs of re-admissions, medications, invasive and non-invasive procedures, and devices used for patients with systolic HF and link them to their survival and quality of life.